PRINCETON, NJ--(Marketwire - February 28, 2008) - Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company that develops and markets dermatology products, today announced its financial results for the fourth quarter and year ended December 31, 2007. Total revenues increased to $9.7 million for the fourth quarter of 2007 from $7.5 million in the third quarter of 2007, which represents 29% sequential growth. Net loss for the fourth quarter of 2007 of $10.1 million, or $0.29 per share, represents a decline of $2.4 million, or 19% from the net loss of $12.5 million, or $0.41 per share in the third quarter of 2007.
